News

360Dx — Proteomics International Laboratories Transfers Diabetic Kidney Disease Test Tech to Atturos

NEW YORK — Proteomics International Laboratories said on Thursday that it has completed the transfer of the technology underlying its PromarkerD test for diabetic kidney disease to Irish clinical diagnostics firm Atturos.

According to Proteomics International, Atturos will make the mass spectrometry-based laboratory developed test available to licensing partners in Europe. Separately, Proteomics International announced today a deal with Patia Europe to launch the test in Spain as a laboratory-developed test through Atturos.

Article: Proteomics International Laboratories Transfers Diabetic Kidney Disease Test Tech to Atturos

ASX Release

Subscribe
  • This field is for validation purposes and should be left unchanged.